Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Li, Ning ^a   Long, Yunzhu ^b   Fan, Xuegong ^a   Liu, Hongbo ^a   Li, Cui ^c   Chen, Lizhang ^d   Wang, Zhiming ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b ZHUZHOU CENTRAL HOSPITAL   (China)

^c BEIJING HOSPITAL   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CARRIER PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 9; RHO FACTOR; RHO GTPASE ACTIVATING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER TISSUE; CHRONIC DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION; GENE EXPRESSION PROFILING; GENETICS; IMAGE PROCESSING; LIVER TUMOR; MASS SPECTROMETRY; METABOLISM; TWO DIMENSIONAL GEL ELECTROPHORESIS; VIROLOGY;

CARCINOMA, HEPATOCELLULAR; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION PROFILING; HEPATITIS B, CHRONIC; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER CIRRHOSIS; LIVER NEOPLASMS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; UP-REGULATION;

EID: 70349255692     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-122     Document Type: Article

References (33)

1. Chronic hepatitis B in hepatocarcinogenesis. NH Park IH Song YH Chung, Postgrad Med J 2006 82 970 507 515 10.1136/pgmj.2006.047431 16891440
2. Prognostic significance of osteopontin in hepatitis B virus-related hepatocellular carcinoma. H Xie J Song R Du K Liu J Wang H Tang F Bai J Liang T Lin J Liu D Fan, Dig Liver Dis 2007 39 2 167 172 10.1016/j.dld.2006.10.015 17161983
3. Proteomics for the early detection and treatment of hepatocellular carcinoma. JT Feng S Shang L Beretta, Oncogene 2006 25 27 3810 3817 10.1038/sj.onc.1209551 16799622
4. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Bruix M Sherman JM Llovet M Beaugrand R Lencioni AK Burroughs E Christensen L Pagliaro M Colombo J Rodés EASL Panel of Experts on HCC, J Hepatol 2001 35 3 421 430 10.1016/S0168-8278(01)00130-1 11592607
5. Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C. JF Blanc C Lalanne C Plomion JM Schmitter K Bathany JM Gion P Bioulac-Sage C Balabaud M Bonneu J Rosenbaum, Proteomics 2005 5 14 3778 3789 10.1002/pmic.200401194 16097030
6. Proteome analysis of human lung squamous carcinoma. C Li Z Xiao Z Chen X Zhang J Li X Wu X Li H Yi M Li G Zhu S Liang, Proteomics 2006 6 2 547 558 10.1002/pmic.200500256 16342241
7. Proteomic analysis of the aging-related proteins in human normal colon epithelial tissue. M Li ZQ Xiao ZC Chen JL Li C Li PF Zhang MY Li, J Biochem Mol Biol 2007 40 1 72 81 17244485
8. Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis. AL Cheng WG Huang ZC Chen F Peng PF Zhang MY Li F Li JL Li C Li H Yi B Yi ZQ Xiao, Clin Cancer Res 2008 14 2 435 445 10.1158/1078-0432.CCR-07-1215 18223218
9. Molecular mechanisms underlying the development of hepatocellular carcinoma. EK Bergsland, Semin Oncol 2001 28 5 521 531 10.1016/S0093-7754(01) 90145-9 11685745
10. Management of hepatitis B: 2000 - summary of a workshop. AS Lok EJ Heathcote JH Hoofnagle, Gastroenterology 2001 120 7 1828 1853 10.1053/gast.2001.24839 11375963
11. SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma. YJ Huang C Xuan BB Zhang M Liao KF Deng M He JM Zhao, J Exp Clin Cancer Res 2009 28 85 10.1186/1756-9966-28-85 19534814
12. Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma. NP Lee L Chen MC Lin FH Tsang C Yeung RT Poon J Peng X Leng L Beretta S Sun PJ Day JM Luk, J Proteome Res 2009 8 3 1293 303 10.1021/pr800637z 19161326
13. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease. NT Zinkin F Grall K Bhaskar HH Otu D Spentzos B Kalmowitz M Wells M Guerrero JM Asara TA Libermann NH Afdhal, Clin Cancer Res 2008 14 7 470 477 10.1158/1078-0432.CCR-07-0586 18223221
14. CDC27Hs colocalizes with CDC16Hs to the centrosome and mitotic spindle and is essential for the metaphase to anaphase transition. S Tugendreich J Tomkiel W Earnshaw P Hieter, Cell 1995 81 2 261 268 10.1016/0092-8674(95)90336-4 7736578
15. Expression patterns of cell cycle and apoptosis-related genes in a multidrug-resistant human colon carcinoma cell line. CW Fan CC Chan CC Chao HA Fan DL Sheu EC Chan, Scand J Gastroenterol 2004 39 5 464 469 10.1080/00365520310008809 15180185
16. Molecular mechanisms of resveratrol action in lung cancer cells using dual protein and microarray analyses. L Whyte YY Huang K Torres RG Mehta, Cancer Res 2007 67 24 12007 12017 10.1158/0008-5472.CAN-07-2464 18089832
17. Molecular biological and quantitative abnormalities of ADP/ATP carrier protein in cardiomyopathic hamsters. M Kato S Yamashina N Takeda S Mochizuki T Morishita M Nagano, Eur Heart J 1995 16 Suppl O 78 80 8682109
18. The role of the ADP/ATP carrier in the pathogenesis of viral heart disease. K Schulze HP Schultheiss, Eur Heart J 1995 16 Suppl O 64 67 8682105
19. Identification of genes differentially expressed in breast cancer cell line SKBR3: potential identification of new prognostic biomarkers. M Leirdal M Shadidy Røsok M Sioud, Int J Mol Med 2004 14 2 217 222 15254768
20. ARHGAP4 is a novel RhoGAP that mediates inhibition of cell motility and axon outgrowth. DL Vogt CD Gray WS Young 3rd SA Orellana AT Malouf, Mol Cell Neurosci 2007 36 3 332 342 10.1016/j.mcn.2007.07.004 17804252
21. Chromosome 13q12 encoded Rho GTPase activating protein suppresses growth of breast carcinoma cells, and yeast two-hybrid screen shows its interaction with several proteins. GM Nagaraja RP Kandpal, Biochem Biophys Res Commun 2004 313 3 654 665 10.1016/j.bbrc.2003.12.001 14697242
22. Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell lines. V Ullmannova NC Popescu, Cancer Detect Prev 2007 31 2 110 118 10.1016/j.cdp.2007.02.005 17418982
23. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma. CM Wong JW Yam YP Ching TO Yau TH Leung DY Jin IO Ng, Cancer Res 2005 65 19 8861 8868 10.1158/0008-5472.CAN-05-1318 16204057
24. Transcriptional Regulation of the Antioxidant Protein 2Gene, a Thiol-specific Antioxidant, by Lens Epithelium-derived Growth Factor to Protect Cells from Oxidative Stress. N Fatma DP Singh T Shinohara LT Chylack Jr, J Biol Chem 2001 276 52 48899 48907 10.1074/jbc.M100733200 11677226
25. Polyol pathway-dependent osmotic and oxidative stresses in aldose reductase-mediated apoptosis in human lens epithelial cells: role of AOP2. E Kubo T Urakami N Fatma Y Akagi DP Singh, Biochem Biophys Res Commun 2004 314 4 1050 1056 10.1016/j.bbrc.2004.01.002 14751239
26. Oxidative stress with altered element content and decreased ATP level of erythrocytes in hepatocellular carcinoma and colorectal liver metastases. L Vli O Hahn P Kupcsulik A Drahos E Srvry K Szentmihlyi Z Pallai T Kurucz P Sípos A Blzovics, Eur J Gastroenterol Hepatol 2008 20 5 393 398 10.1097/MEG.0b013e3282f495c7 18403940
27. Hepatic oxidative DNA damage is associated with increased risk for hepatocellular carcinoma in chronic hepatitis C. H Tanaka N Fujita R Sugimoto N Urawa S Horiike Y Kobayashi M Iwasa N Ma S Kawanishi S Watanabe M Kaito Y Takei, Br J Cancer 2008 98 3 580 586 10.1038/sj.bjc.6604204 18231107 (Pubitemid 351214532)
28. Proteomic analysis of cancer tissues: Shedding light on carcinogenesis and possible biomarkers. Y Kuramitsu K Nakamura, Proteomics 2006 6 20 5650 5661 10.1002/pmic.200600218 16972299
29. Genetic polymorphism in the manganese superoxide dismutase gene is associated with an increased risk for hepatocellular carcinoma in HCV-infected Moroccan patients. S Ezzikouri AE El Feydi A Chafik R Afifi L El Kihal M Benazzouz M Hassar P Pineau S Benjelloun, Mutat Res 2008 649 1-2 1 6 18023606
30. High molecular mass proteome of androgen-independent prostate cancer. H Kuruma S Egawa M Oh-Ishi Y Kodera M Satoh W Chen H Okusa K Matsumoto T Maeda S Baba, Proteomics 2005 5 4 1097 1112 10.1002/pmic.200401115 15712236
31. Proteome analysis of butyrate-treated human colon cancer cells (HT-29). S Tan TK Seow RC Liang S Koh CP Lee MC Chung SC Hooi, Int J Cancer 2002 98 4 523 531 10.1002/ijc.10236 11920611
32. Human mitochondrial C1-tetrahydrofolate synthase: gene structure, tissue distribution of the mRNA, and immunolocalization in Chinese hamster ovary calls. P Prasannan S Pike K Peng B Shane DR Appling, J Biol Chem 2003 278 44 43178 43187 10.1074/jbc.M304319200 12937168
33. Characterization of the rat cytoplasmic C1-tetrahydrofolate synthase gene and analysis of its expression in liver regeneration and fetal development. KM Howard SJ Muga L Zhang AE Thigpen DR Appling, Gene 2003 319 85 97 10.1016/S0378-1119(03)00796-0 14597174